CARBOPLATIN (PARAPLATIN)

Course overview

CARBOplatin is U.S. FDA-approved to treat advanced ovarian cancer (initial treatment or treatment of recurrent disease), either as monotherapy or in combination with other agents. It must be used cautiously in older patients, patients who have received prior chemotherapy, and patients with renal impairment. This continuing education module is designed to give the reader/learner an increased understanding of carboplatin. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.